Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Winners Of ASCO 2012
Seeking Alpha
The 9 Biotechs With The Highest Growth Expectations
Seeking Alpha
FDA Approves Roche, Curis Skin-Cancer Drug
TheStreet.com
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
- Amarin
- Amgen
- AMR101
- Amylin
- Ariad
- Avanafil
- Bio-T-Gel
- Biogen Idec
- BioSante
- Bristol-Myers Squibb
- Bydureon
- Carfilzomib
- Cell Therapeutics
- Chelsea Therapeutics
- Corcept Therapeutics
- Corlux
- Curis
- Dapagliflozin
- Discovery Labs
- Elan
- Eliquis
- Ironwood
- Kalydeco
- Levadex
- linaclotide
- MAP Pharmaceuticals
- Merck
- Northera
- ONYX Pharmaceuticals
- Pfizer
- pixantrone
- Protalix BioTherapeutics
- Qnexa
- ridaforolimus
- Roche
- Surfaxin
- Teva Pharmaceuticals
- Tysabri
- Uplypso
- Vertex
- vismodegib
- Vivus
- Xgeva
Curis Earns $8 Million Milestone As NDA Accepted By FDA
Seeking Alpha

